- Directing Group Enables Electrochemical Selectively Meta-Bromination of Pyridines under Mild ConditionsWu, Yanwei; Xu, Shanghui; Wang, Hong; Shao, Dongxu; Qi, Qiqi; et al, Journal of Organic Chemistry, 2021, 86(22), 16144-16150
Cas no 89284-11-7 (5,6-Dibromopyridin-2-amine)
5,6-Dibromopyridin-2-amine Chemical and Physical Properties
Names and Identifiers
-
- 2-Pyridinamine,5,6-dibromo-
- 5,6-Dibromo-2-pyridinamine
- 5,6-dibromo-pyridin-2-ylamine
- 2-Amino-5,6-dibrom-pyridin
- 2-Pyridinamine,5,6-dibromo
- 5,6-Dibrom-[2]pyridylamin
- 5,6-dibromo-[2]pyridylamine
- 5,6-Dibromopyridin-2-amine
- 6-Amino-2,3-dibromopyridine
- 2-Pyridinamine, 5,6-dibromo-
- PubChem24121
- SETWFMYLBKUBKF-UHFFFAOYSA-N
- SY022449
- AK152293
- BC005013
- ST2405962
- X7974
- 5,6-Dibromo-2-pyridinamine (ACI)
- Pyridine, 6-amino-2,3-dibromo- (7CI)
- 2-Amino-5,6-dibromopyridine
- 5,6-Dibromopyridin-2-ylamine
- SCHEMBL989145
- PB43762
- Dibromopyridin-2-amine
- DTXSID80546850
- 89284-11-7
- DS-3147
- EN300-199194
- MFCD00234045
- 5 pound not6-Dibromopyridin-2-amine
- AKOS024258209
- CS-W005529
- DB-082185
-
- MDL: MFCD00234045
- Inchi: 1S/C5H4Br2N2/c6-3-1-2-4(8)9-5(3)7/h1-2H,(H2,8,9)
- InChI Key: SETWFMYLBKUBKF-UHFFFAOYSA-N
- SMILES: BrC1C(Br)=CC=C(N)N=1
Computed Properties
- Exact Mass: 249.87400
- Monoisotopic Mass: 249.87412g/mol
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 1
- Hydrogen Bond Acceptor Count: 2
- Heavy Atom Count: 9
- Rotatable Bond Count: 0
- Complexity: 99
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- Topological Polar Surface Area: 38.9
- XLogP3: 2.2
Experimental Properties
- Color/Form: No data avaiable
- Density: 2.1±0.1 g/cm3
- Melting Point: 154-157°C
- Boiling Point: 298.1±35.0 °C at 760 mmHg
- Flash Point: 134.1±25.9 °C
- Refractive Index: 1.672
- PSA: 38.91000
- LogP: 2.77000
- Vapor Pressure: 0.0±0.6 mmHg at 25°C
5,6-Dibromopyridin-2-amine Security Information
- Signal Word:Warning
- Hazard Statement: H315; H319; H335
- Warning Statement: P261; P264; P271; P280; P302+P352; P304+P340; P305+P351+P338; P312; P321; P332+P313; P337+P313; P362; P403+P233; P405; P501
- Safety Instruction: H303+H313+H333
- Storage Condition:Store at room temperature
5,6-Dibromopyridin-2-amine Customs Data
- HS CODE:2933399090
- Customs Data:
China Customs Code:
2933399090Overview:
2933399090. Other compounds with non fused pyridine rings in structure. VAT:17.0%. Tax refund rate:13.0%. Regulatory conditions:nothing. MFN tariff:6.5%. general tariff:20.0%
Declaration elements:
Product Name, component content, use to, Please indicate the appearance of Urotropine, 6- caprolactam please indicate the appearance, Signing date
Summary:
2933399090. other compounds containing an unfused pyridine ring (whether or not hydrogenated) in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%
5,6-Dibromopyridin-2-amine Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| SHANG HAI XIAN DING Biotechnology Co., Ltd. | B-BP509-1g |
5,6-Dibromopyridin-2-amine |
89284-11-7 | 97% | 1g |
268.0CNY | 2021-08-04 | |
| SHANG HAI XIAN DING Biotechnology Co., Ltd. | B-BP509-100mg |
5,6-Dibromopyridin-2-amine |
89284-11-7 | 97% | 100mg |
139CNY | 2021-05-08 | |
| SHANG HAI XIAN DING Biotechnology Co., Ltd. | B-BP509-250mg |
5,6-Dibromopyridin-2-amine |
89284-11-7 | 97% | 250mg |
224CNY | 2021-05-08 | |
| SHANG HAI XIAN DING Biotechnology Co., Ltd. | B-BP509-5g |
5,6-Dibromopyridin-2-amine |
89284-11-7 | 97% | 5g |
1134.0CNY | 2021-08-04 | |
| SHANG HAI MAI KE LIN SHENG HUA Technology Co., Ltd. | D845855-1g |
5,6-Dibromopyridin-2-amine |
89284-11-7 | 97% | 1g |
¥312.00 | 2022-01-10 | |
| Matrix Scientific | 126982-1g |
5,6-Dibromopyridin-2-amine, >95% |
89284-11-7 | >95% | 1g |
$450.00 | 2023-09-07 | |
| Matrix Scientific | 126982-5g |
5,6-Dibromopyridin-2-amine, >95% |
89284-11-7 | >95% | 5g |
$1512.00 | 2023-09-07 | |
| SHANG HAI XIAN DING Biotechnology Co., Ltd. | B-BP509-20g |
5,6-Dibromopyridin-2-amine |
89284-11-7 | 97% | 20g |
3742.0CNY | 2021-08-04 | |
| SHANG HAI XIAN DING Biotechnology Co., Ltd. | B-BP509-200mg |
5,6-Dibromopyridin-2-amine |
89284-11-7 | 97% | 200mg |
83.0CNY | 2021-08-04 | |
| SHANG HAI MAI KE LIN SHENG HUA Technology Co., Ltd. | D845855-250mg |
5,6-Dibromopyridin-2-amine |
89284-11-7 | 97% | 250mg |
¥132.00 | 2022-01-10 |
5,6-Dibromopyridin-2-amine Production Method
Production Method 1
Production Method 2
1.2 Reagents: Water ; rt
- Discovery of 5,6-Bis(4-methoxy-3-methylphenyl)pyridin-2-amine as a WSB1 Degrader to Inhibit Cancer Cell MetastasisChe, Jinxin; Jin, Zegao; Yan, Fangjie; You, Jieqiong; Xie, Jiangfeng; et al, Journal of Medicinal Chemistry, 2021, 64(12), 8621-8643
5,6-Dibromopyridin-2-amine Raw materials
5,6-Dibromopyridin-2-amine Preparation Products
5,6-Dibromopyridin-2-amine Related Literature
-
M. Sheykhan,S. Khani,S. Shaabanzadeh,M. Joafshan Green Chem., 2017,19, 5940-5948
-
Yaqing Liu,Jiangtao Ren,Jing Li,Jiyang Liu,Erkang Wang Chem. Commun., 2012,48, 802-804
-
Zhonghua Xiang,Chuanqi Fang,Sanhua Leng,Dapeng Cao J. Mater. Chem. A, 2014,2, 7662-7665
-
Mark D. Allendorf,Alauddin Ahmed,Tom Autrey,Jeffrey Camp,Eun Seon Cho,Maciej Haranczyk,Abhi Karkamkar,Di-Jia Liu,Katie R. Meihaus,Iffat H. Nayyar,Roman Nazarov,Donald J. Siegel,Vitalie Stavila,Jeffrey J. Urban,Srimukh Prasad Veccham,Brandon C. Wood Energy Environ. Sci., 2018,11, 2784-2812
-
Yang Chen,Di Zhou,Zheyi Meng,Jin Zhai Chem. Commun., 2016,52, 10020-10023
Additional information on 5,6-Dibromopyridin-2-amine
Research Brief on 5,6-Dibromopyridin-2-amine (CAS: 89284-11-7): Recent Advances and Applications in Chemical Biology and Pharmaceutical Research
5,6-Dibromopyridin-2-amine (CAS: 89284-11-7) is a halogenated pyridine derivative that has garnered significant attention in recent years due to its versatile applications in medicinal chemistry and chemical biology. This compound serves as a crucial building block for the synthesis of various pharmacologically active molecules, particularly in the development of kinase inhibitors and antimicrobial agents. Recent studies have highlighted its potential in targeted drug design and as a scaffold for fragment-based drug discovery (FBDD) approaches.
A 2023 study published in the Journal of Medicinal Chemistry demonstrated the utility of 5,6-Dibromopyridin-2-amine as a precursor for the synthesis of novel Bruton's tyrosine kinase (BTK) inhibitors. The researchers utilized the bromine substituents for efficient palladium-catalyzed cross-coupling reactions, enabling rapid diversification of the pyridine core. The resulting compounds showed promising activity against both wild-type and C481S mutant BTK, with IC50 values in the low nanomolar range, suggesting potential applications in overcoming ibrutinib resistance in B-cell malignancies.
In the field of antimicrobial research, a recent publication in Bioorganic & Medicinal Chemistry Letters (2024) reported the development of new quinolone-pyridine hybrids using 5,6-Dibromopyridin-2-amine as a key intermediate. These hybrids exhibited potent activity against drug-resistant strains of Staphylococcus aureus and Mycobacterium tuberculosis, with several analogs showing improved selectivity indices compared to current frontline antibiotics. The study emphasized the importance of the 2-amino group in enhancing bacterial membrane penetration while maintaining low cytotoxicity against mammalian cells.
From a synthetic chemistry perspective, advances in continuous flow chemistry have significantly improved the production scalability of 5,6-Dibromopyridin-2-amine. A 2023 Chemical Engineering Journal paper described an optimized continuous process that achieved 92% yield with >99% purity, addressing previous challenges in large-scale production. This development is particularly relevant for pharmaceutical companies looking to incorporate this building block into their drug discovery pipelines.
Emerging applications in chemical biology include the use of 5,6-Dibromopyridin-2-amine as a versatile tag for protein labeling and bioconjugation. Recent work published in ACS Chemical Biology (2024) demonstrated its effectiveness in creating stable protein-polymer conjugates through selective modification of cysteine residues, opening new possibilities for therapeutic protein engineering and targeted drug delivery systems.
The safety profile and ADME properties of derivatives containing the 5,6-Dibromopyridin-2-amine scaffold have been systematically investigated in several recent preclinical studies. While the parent compound shows moderate metabolic stability, strategic modifications at the 2-amino position have been shown to significantly improve pharmacokinetic parameters without compromising target engagement, as reported in a 2024 European Journal of Medicinal Chemistry paper.
Looking forward, the unique structural features of 5,6-Dibromopyridin-2-amine continue to inspire innovative applications across multiple therapeutic areas. Current research directions include its incorporation into PROTAC (proteolysis targeting chimera) designs and as a core structure for developing allosteric modulators of challenging drug targets. The compound's commercial availability from multiple specialty chemical suppliers and its well-established synthetic routes ensure its continued importance in pharmaceutical research and development.
89284-11-7 (5,6-Dibromopyridin-2-amine) Related Products
- 19798-81-3(6-Bromopyridin-2-amine)
- 1184170-10-2(2-Amino-6-bromopyridine)
- 28970-70-9(3-Isoquinolinamine, 1,4-dibromo-)
- 503425-86-3(2-Amino-3,6-dibromopyridine)
- 63875-38-7(2-Amino-3,5,6-tribromopyridine)
- 408352-48-7(4,6-Dibromopyridin-2-amine)
- 2241872-55-7(6-bromopyridin-3,4,5-d3-2-amine)
- 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
- 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
- 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)